Healthcare Services

CRISPR-based diagnostics market forecast to reach $11.44B by 2030

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The CRISPR-Based Diagnostics Market Grow Between 2026 And 2030?

The crispr-based diagnostics market size has seen rapid growth in recent years. It is anticipated to expand from $5.1 billion in 2025 to $6.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.8%. This historical increase can be attributed to the necessity for swift and accurate diagnostics, the limitations of conventional molecular tests, the heightened diagnostic demand driven by pandemics, breakthroughs in crispr detection methods, and the academic validation of crispr diagnostics.

The crispr-based diagnostics market is projected to experience substantial expansion in the coming years, reaching a valuation of $11.45 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast period stems from factors such as the increasing prevalence of decentralized testing models, a heightened need for early disease identification, the broadening scope of point-of-care diagnostics, their seamless integration with digital health platforms, and their growing use in oncology and genetic screening. Significant trends during this period are expected to include the rising uptake of rapid molecular diagnostics, the continued development of point-of-care testing solutions, their expanded application in detecting infectious diseases, their integration with isothermal amplification techniques, and the emergence of personalized diagnostic applications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Major Drivers Are Influencing The Expansion Of The CRISPR-Based Diagnostics Market?

The escalating occurrence of infectious diseases is anticipated to fuel the expansion of the CRISPR-based diagnostics market in the foreseeable future. Infectious diseases are defined as ailments stemming from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly among individuals, through tainted surfaces, food, water, or vectors like insects. The frequency of these diseases is on the rise due to various factors including globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and inadequate access to healthcare. CRISPR-based diagnostics enhance the combat against infectious diseases by providing rapid and accurate pathogen detection, thereby facilitating early diagnosis, timely intervention, and effective containment measures. For instance, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, revealed that England’s UKHSA reported 368 measles cases in 2023, signifying a nearly sevenfold increase from the 53 cases documented in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the increasing incidence of infectious diseases is a primary driver for the CRISPR-based diagnostics market.

How Are Segments Identified Within The CRISPR-Based Diagnostics Market Segment Framework?

The crispr-based diagnostics market covered in this report is segmented –

1) By Product: Kits, Buffer Solutions, Software, Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-Mediated Isothermal Amplification (LAMP), Other Techniques

3) By Disease: Infectious Diseases, Non-Infectious Diseases

4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

Which Trends Are Shaping The CRISPR-Based Diagnostics Market?

Key players within the CRISPR-based diagnostics market are concentrating on forging strategic partnerships to boost the availability of fast and precise diagnostic solutions via CRISPR-based point-of-care tests. Such a partnership represents a sustained collaboration between multiple entities, pooling resources and specialized knowledge to achieve shared objectives and bolster their competitive standing. An illustrative example occurred in August 2023, when CrisprBits Private Limited, an India-based biotechnology firm, declared a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics enterprise, for the development of CRISPR-based Point-of-Care Tests (POCTs). The essence of this partnership lies in crafting swift, accurate, and economical diagnostic instruments utilizing CRISPR technology for identifying pathogens and genetic markers. These POCTs are designed to broaden diagnostic access across various environments, notably in resource-constrained regions, concurrently guaranteeing prompt and precise disease identification. This alliance merges CrisprBits’ proficiency in CRISPR-based platforms with Molbio’s manufacturing and distribution infrastructure, aiming to introduce these diagnostic tests to a global audience.

Who Are The Companies Competing Within The CRISPR-Based Diagnostics Market?

Major companies operating in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Epic Bio, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc., Caspr Biotech, GenScript, Twist Bioscience, Revvity Discovery Limited, Danaher Corporation, Scope Biosciences, CRISPR Diagnostics, Gene Editing Institute, Aptitude Medical Systems, Qiagen, Abingdon Health

Get The Full CRISPR-Based Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Region Is The Top Contributor To The CRISPR-Based Diagnostics Market By Share?

North America was the largest region in the CRISPR-based diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr-based diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized CRISPR-Based Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2026, By The Business Research Company

Plant Breeding And Crispr Plants Market Report 2026

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795